Anticancer Research · 2016 · 24 citations · 16 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyNeuro-oncologyBrain TumorsGlioblastomaMicrorna BiologyMolecular Tumor ProfilingNoncoding Rna BiologyNoncoding Rna In CancerFrozen Section SpecimensGlioblastoma BiomarkersGlioblastoma PrognosisMicrorna In CancerMicrorna ProfilingMicrorna Prognostic MarkersMicrorna Regulation In CancerQuantitative Pcr Detection
Glioblastoma is the most common primary malignant tumor of the adult human brain. Although microRNA-126 (miR-126) has been reported to exhibit expression abnormalities in various types of cancer, to date very few studies have examined changes in miR-126 level in glioblastoma. In this pilot study, we investigated the changes in miR-126 expression in newly-dissected primary glioblastoma to explore possible roles of miR-126 in patient prognosis. Total RNA was extracted from tumoral and adjacent non-cancerous tissues from 14 patients' paired frozen specimens. Using an established quantitative reverse transcriptase-PCR protocol, the levels of miR-126 in glioblastoma and adjacent non-tumor brain tissues were compared against small nucleolar RNA U48 (RNU48) as a reference gene. The expression of miR-126 in glioblastoma samples was significantly lower than in paired non-tumoral controls (p<0.05). Importantly, age-adjusted analyses suggest that glioblastoma patients with higher relative intratumoral miR-126 expression (i.e. 53-79% relative to that of the control tissue; n=7) had significantly improved survival duration than patients whose miR-126 levels were lower (i.e. 12-48%, n=7; stratified log-rank analysis p=0.011 when the dividing threshold was set at ≥51%; total: n=14, male: 8; female: 6). Thus, intraglioblastoma miR-126 may be down-regulated relative to normal tissue and patients with less down-regulation of intratumoral miR-126 expression could have improved postsurgical prognosis. Future clinical studies with larger sample sizes should be performed to validate this observation.
16
miR-126 Regulates Angiogenic Signaling and Vascular Integrity
Jason E. Fish, Massimo Santoro, Sarah U. Morton et al. · Developmental Cell · 2008 · 1.7K citations · Full text
The cell growth suppressor, mir-126, targets IRS-1
Jin Zhang, Yingying Du, Yifeng Lin et al. · Biochemical and Biophysical Research Communications · 2008 · 233 citations